Navigation Links
Evalve MitraClip: Clinical trial of nonsurgical repair for severe mitral valve regurgitation
Date:6/19/2008

LOS ANGELES (June 18, 2008) -- The Cedars-Sinai Heart Institute is the lead enroller in the world for the Everest II Clinical Trial a study comparing non-surgical repair for severe mitral valve regurgitation with conventional surgery. In 2005, a team of doctors at the Institute implanted the first Evalve MitraClip in California, and was also first on the West Coast to insert two clips during a single procedure. Cedars-Sinai is believed to be the most experienced center in the nation with any form of percutaneous mitral valve repair.

About four million Americans have significant mitral valve regurgitation, with 250,000 new patients diagnosed each year.

The mitral valve consists of two "leaflets" that act as swinging doors between the left atrium and the left ventricle. If the valve fails to close properly, blood flows backward into the atrium (regurgitation), leaving the left ventricle, the heart's primary pumping chamber, with too little blood. To compensate, the ventricle stretches and overworks. Over time, it undergoes a process called remodeling, becoming enlarged, distorted and weak.

The MitraClip procedure is performed in a cardiac catheterization laboratory with the patient under general anesthesia. A thin, flexible tube (catheter) is inserted through a small incision in the groin and guided through the femoral vein to the affected area of the heart. A smaller catheter holding the clip is slipped through the first catheter. After the clip is attached to the valve leaflets, the catheters are removed. The patient is released from the hospital within a day or two.

While the procedure is complex and challenging, requiring a coordinated effort among echocardiographers, interventional cardiologists, anesthesiologists and other team members, it is also somewhat forgiving. If the clip is not placed ideally on the first attempt, it can be reset. If it does not sufficiently correct the regurgitation, surgical repair or replaceme
'/>"/>

Contact: Sandy Van
sandy@prpacific.com
800-880-2397
Cedars-Sinai Medical Center
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. Correction: Evalve Announces CE Mark Approval of the Worlds First Percutaneous Valve Repair System
2. Evalve Announces CE Mark Approval of the Worlds First Percutaneous Valve Repair System
3. Edwards Lifesciences Initiates Patent Infringement Litigation Against CoreValve in the U.S.
4. UPDATED: Evalve(R) Completes $60 Million Series D Financing
5. Evalve(R) Completes $60 Million Series D Financing
6. Effective Communication of Clinical Studies for Maximum Impact
7. Ease-of-Use and Intuitive Nature of the DATATRAK eClinical(TM) Platform Allows for Further Operational Efficiencies
8. INACSL and Elsevier partner to publish Clinical Simulation in Nursing
9. Winning Method - Effective Identification and Development of Clinical Investigators
10. Abatacept and infliximab improve clinical response over time in methotrexate-refractory RA patients
11. New insight into RA patient priorities and motivators for clinical trial involvement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... are critical for determining effectiveness of medical therapies, ... for these studies compared with other western countries, ... Canadian Medical Association Journal ). , Dr. Salim ... Ontario, with Dr. John Cairns, University of British ... Canada should provide better financial support of clinical ...
(Date:5/22/2012)... LEXINGTON, Ky. (May 17, 2012) The University of ... million to study a deadly blood and bone marrow ... $5 million grant from the Edward P. Evans Foundation, ... research of myelodysplastic syndrome (MDS). , The Evans Foundation ... including three labs at UK, one at Cincinnati Children,s ...
(Date:5/22/2012)... (Phoenix, AZ May 22, 2012) -- Researchers at ... Medical Center have unveiled how and why the ... that could have real-world implications in military tactics, ... Barrow,s Laboratory of Visual Neuroscience, and Stephen Macknik, ... well known for their research into magic and ...
(Date:5/22/2012)... Alan Mozes HealthDay Reporter , , TUESDAY, May ... some headway is being made in both the detection ... front, researchers from two Cleveland institutions said they have ... kick-start the patient,s immune system into attacking cancer cells. ... School of Medicine and the Seidman Cancer Center at ...
(Date:5/22/2012)... 2012) -- Up to half of all prostate cancer cells ... gene and formation of its unique protein -- but no ... Weill Cornell Medical College researchers have found that in these ... a little ball known as a chromatin, is warped in ... thousands of genes, turning them on or off to promote ...
Breaking Medicine News(10 mins):Health News:Canada should significantly increase its funding of randomized clinical trials 2Health News:Markey receives $6.25 million to study deadly blood and bone marrow disease 2Health News:Markey receives $6.25 million to study deadly blood and bone marrow disease 3Health News:Barrow researchers use magic for discoveries 2Health News:Studies See Advances in Detecting, Treating Pancreatic Cancer 2Health News:Studies See Advances in Detecting, Treating Pancreatic Cancer 3Health News:Studies See Advances in Detecting, Treating Pancreatic Cancer 4Health News:Scientists unravel role of fusion gene in prostate cancer 2Health News:Scientists unravel role of fusion gene in prostate cancer 3Health News:Scientists unravel role of fusion gene in prostate cancer 4
... Ancient DNA samples recovered from the bottom of a two-kilometre ... was much warmer at some point during the last Ice ... from the trees, plants and insects of a boreal forest ... the youngest evidence of a boreal forest in Greenland was ...
... University researcher is experimenting with ways to add fibre to ... our favourite snacks . ,Sajid Alavi is an ... of Agriculture. ,His expertise is in extrusion ... to pet food. ,Alavi is researching how ...
... results from its Phase 1 clinical studies using two ... an estrogen . ,The first study was ... a formulation combining Nestorone and the synthetic estrogen, Ethinyl ... applied to the forearm of healthy volunteers. ...
... closer to the jawbone and opens up the airways might ... early results of a study . ,Snoring is ... to obstructed air movement during breathing while sleeping. The sound ... be frustrating for patients and their loved ones. ...
... vegetable are healthier than conventionally grown products. A US ... pressure and lower the risk of heart disease ... organic tomatoes with standard produce found almost double the ... contained higher levels of quercetin and kaempferol aglycones than ...
... annual San Fermin running of the bulls festival on Friday, ... will take their chances in the bull run . ... to mention copious amounts of drinking -- in Pamplona in ... worldwide for the "encierro", when bulls are released onto the ...
Other Medicine News:Health News:Now, Fibre-enriched Tasty Snacks in the Making 2Health News:Contraceptive Spray Shows Positive Clinical Trial Result 2Health News:New Device to Treat Snoring and Sleep Apnea 2Health News:Organically Grown Food More Healthier 2
(Date:5/22/2012)... Serbia, May 22, 2012 Sorbent Therapeutics, ... and renal diseases, presented positive data from its ... study of 111 heart failure patients with chronic ... symptoms as compared to placebo.    ... were presented in an oral session at the ...
(Date:5/22/2012)... -- GeoVax Labs, Inc. (OTCQB/OTCBB: GOVX), an Atlanta-based ... Human Immunodeficiency Virus (HIV) infections, today announced that ... opened enrollment for a Phase 1 trial for ... is identical to the first generation ... for the inclusion of granulocyte-macrophage colony-stimulating factor (GM-CSF) ...
(Date:5/22/2012)...   USANA Health Sciences , Inc. (NYSE: ... announced the promotion of Dr. John Cuomo to executive ... Dixon to executive director of new product and technological ... Mark Levy, a Ph.D. in human nutrition, and John ... professor at the University of Utah, have joined USANA,s ...
Breaking Medicine Technology:Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study 2Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study 3HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 2HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 3HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine 4USANA Health Sciences Expands Award-Winning Research and Development Team 2USANA Health Sciences Expands Award-Winning Research and Development Team 3Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution 20047 1Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution 20047 2Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution 20047 3Access Pharmaceuticals and CuraScript Team Up to Further Expand MuGard Market Access and Distribution 20047 4PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes 20044 1PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes 20044 2Debiopharm and Ascenta Therapeutics Inc Announce An Exclusive License Agreement for the Development and Commercialization of the IAP 28Inhibitor of 20439 1Debiopharm and Ascenta Therapeutics Inc Announce An Exclusive License Agreement for the Development and Commercialization of the IAP 28Inhibitor of 20439 2Debiopharm and Ascenta Therapeutics Inc Announce An Exclusive License Agreement for the Development and Commercialization of the IAP 28Inhibitor of 20439 3
... week ARTEMIS data presented at ICAAC -, ... today from a phase 3, randomized, open-label, ongoing ... infected adults,taking PREZISTA(R) 800 mg (two 400 mg ... an undetectable viral load (<50 copies/mL) at week ...
... Phase III studies affirmed the clinical benefits of,ACTEMRA ... from two Phase III studies,showed that patients who ... arthritis (RA) achieved significant improvements in signs and,symptoms ... combination,with methotrexate compared with methotrexate alone. The final ...
Other Medicine Technology:Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 2Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 3Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 4Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 5Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 6Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 7Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults 8ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 2ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 3ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 4ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 5ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments 6
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: